P. H. Cooper

Papers

Total Citations

H-Index

About

Dr. P. H. Cooper is a leading gynecologic oncologist whose research centers on improving surgical management and outcomes for patients with endometrial hyperplasia and uterine malignancies. Dr. Cooper’s major contribution lies in advancing the use of sentinel lymph node (SLN) mapping for complex atypical endometrial hyperplasia (CAH), a high-risk precursor to endometrial cancer. In a pivotal 2024 study (3 citations), Dr. Cooper demonstrated that intraoperative evaluation of SLNs can safely and sensitively detect occult malignancy in CAH cases, addressing the longstanding challenge of unreliable frozen-section analysis. This work has helped validate SLN sampling as a standard, less-invasive alternative to full lymphadenectomy, reducing surgical morbidity while preserving diagnostic accuracy. Dr. Cooper’s research directly impacts clinical decision-making, offering patients with CAH a more precise, personalized surgical approach. With a growing citation footprint, Dr. Cooper continues to shape guidelines for sentinel node assessment in high-risk endometrial conditions, bridging the gap between hyperplasia diagnosis and cancer staging. Their contributions are widely recognized for translating sentinel node technology into routine practice, improving both safety and oncologic outcomes for women at elevated cancer risk.